Navigation Links
Regulus Therapeutics Appoints Gregory Hannon, Ph.D. to Scientific Advisory Board
Date:7/14/2011

LA JOLLA, Calif., July 14, 2011 /PRNewswire/ -- Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that it has added Gregory Hannon, Ph.D. to its Scientific Advisory Board (SAB). The addition of Dr. Hannon, a researcher whose work has involved the molecular identification and characterization of the microRNA pathway, increases SAB membership to six pioneers in this area of scientific research.

"We are delighted to add Greg to our SAB as he brings new insights to the already outstanding group of scientific advisors aiding us in the understanding of microRNA biology," said Neil W. Gibson, Ph.D., chief scientific officer of Regulus. "Greg is a world-renowned researcher with expertise in small regulatory RNAs and an understanding of the molecular mechanisms by which they operate."

"The Regulus SAB includes many of the world's thought leaders in the field of microRNA," said David Baltimore, Ph.D., professor of biology at the California Institute of Technology and Director of Regulus as well as Chairman of Regulus' SAB. "Greg's seminal discoveries in the field of non-coding RNAs include the identification of the enzyme Dicer which cleaves double stranded RNA to produce small RNAs like microRNA. This discovery contributed to Science magazine naming small RNAs the 2002 Breakthrough of the Year."

Dr. Hannon's laboratory has identified and characterized many of the major biogenesis and effector complexes for microRNAs and small interfering RNAs. In addition, the Hannon lab strives to understand the biology of cancer cells, with a focus on the roles of small RNAs as oncogenes and tumor suppressors.

In addition to Dr. Hannon, Regulus' SAB members are:

  • David Baltimore, Ph.D., professor of biology at the California Institute of Technology, member of t
    '/>"/>

SOURCE Regulus Therapeutics Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Regulus Therapeutics and Collaborators from NYU Langone Medical Center Publish New Data Demonstrating Clearance of Cholesterol from Bloodstream and Reduction of Atherosclerotic Plaques through Inhibition of microRNA-33
2. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
3. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
4. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
5. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
6. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
7. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
8. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
9. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
10. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
11. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)...   Taiho Oncology, Inc. , a subsidiary ... ), announced that the U.S. Food and ... TAS-102 (nonproprietary names: trifluridine and tipiracil hydrochloride), an ... treatment of refractory metastatic colorectal cancer (mCRC), and ... submission to the FDA. According to the American ...
(Date:10/20/2014)... 20, 2014 Norgine B.V. today ... low volume bowel preparation, NER1006, presented at the 79 ... of Gastroenterology (ACG), Philadelphia, PA , ... weight and co-primary endpoint of cleansing success. The study ... MOVIPREP ® in screening colonoscopy patients. [1] ...
(Date:10/19/2014)... Oct. 19, 2014  Henry Schein, Inc. (NASDAQ: ... care products and services to office-based dental, animal health ... in Iwase Dental Supply, Inc., a leading full-service provider ... marks Henry Schein,s entrance into Japan ... and increases to 28 the number of countries in ...
Breaking Medicine Technology:Taiho Oncology, Inc. Receives FDA Fast Track Designation for TAS-102 as a Potential Treatment for Refractory Metastatic Colorectal Cancer 2Taiho Oncology, Inc. Receives FDA Fast Track Designation for TAS-102 as a Potential Treatment for Refractory Metastatic Colorectal Cancer 3Taiho Oncology, Inc. Receives FDA Fast Track Designation for TAS-102 as a Potential Treatment for Refractory Metastatic Colorectal Cancer 4Positive Results from Phase II Data Show NER1006 Achieves High Quality Bowel Cleansing Efficacy 2Henry Schein Enters Japan With Investment in Iwase Dental Supply 2Henry Schein Enters Japan With Investment in Iwase Dental Supply 3Henry Schein Enters Japan With Investment in Iwase Dental Supply 4Henry Schein Enters Japan With Investment in Iwase Dental Supply 5
... 5 Only about a third of American women ... means they are likely missing out on potentially important ... vitamins, minerals and fiber, fruits and vegetables contain a ... support women,s health including breast and ovarian health.   ...
... Accuray Incorporated (Nasdaq: ARAY ), ... that the company was awarded a $1 million Small Business ... used toward further development of a high-energy X-ray source for ... development of a next generation, compact X-ray source with unprecedented ...
Cached Medicine Technology:Shortfalls in Carotenoid Intake May Impact Women's Health 2Shortfalls in Carotenoid Intake May Impact Women's Health 3Shortfalls in Carotenoid Intake May Impact Women's Health 4Shortfalls in Carotenoid Intake May Impact Women's Health 5Accuray Awarded $1 Million Grant by U.S. Government 2Accuray Awarded $1 Million Grant by U.S. Government 3
(Date:10/20/2014)... Pittsburgh, PA (PRWEB) October 20, 2014 ... new, minimally-invasive procedure that enables physicians to repair a ... , The MitraClip system, developed by ... regurgitation (MR), a progressive and life-threatening condition in which ... allowing blood to flow backward from the heart’s left ...
(Date:10/20/2014)... hc1.com today announced the launch of ... enables healthcare organizations of all sizes to immediately ... management (“CRM”) solution. , Designed from the ground ... healthcare industry, the hc1 Healthcare Relationship Cloud™ personalizes ... combining healthcare CRM, HIPAA-compliant collaboration, and real-time analytics ...
(Date:10/20/2014)... October 20, 2014 AttorneyOne.com, a recognized authority ... information from the FDA on Sit and Slim II ... not to purchase or use Sit and Slim II because ... II is promoted as weight loss product on various websites ... the market in 2010 for safety reasons, can significantly increase ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 National Teen Driver ... of the American Academy of Pediatrics (Ohio AAP, http://www.ohioaap.org ... in encouraging parents of teen drivers to talk to their ... road. , Motor vehicle crashes are the leading cause of ... drivers involved in fatal crashes, and 859 (42%) of those ...
(Date:10/20/2014)... Houston plastic surgeon Dr. Christopher ... of his innovative True Form Tummy Tuck® ... and faculty at The University of Texas Medical ... once a medical student. Patronella, who is a founding ... surgery practices in Texas, The Aesthetic Center for ...
Breaking Medicine News(10 mins):Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 2Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 3Health News:Healthcare Relationship Management (HRM) Leader hc1.com® Launches hc1® Quick Start™ 2Health News:FDA Advises Not to Use Sit and Slim II: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Ohio AAP Promotes National Teen Driver Safety Week 2Health News:Plastic Surgeon Patronella Presents Artistically-Inspired Tummy Tuck Method to Future Generation of Plastic Surgeons in Texas 2
... ... ... ... BLOOMINGTON, Minn. , March 18 As part of National Colorectal Cancer Awareness Month, four health organizations have kicked off an initiative to increase screenings for Minnesotans at risk ...
... PROLOR Biotech, Inc., (OTC Bulletin Board: PBTH),  a ... it has raised $24.4 million in a private ... $0.00001 per share, to accredited investors at a ... approximate 17% discount to the average closing price of the ...
... , ... of data protection tools for VMWare platform, announced the release and availability of SnapShot Backup ... customers to use SAN snapshots and replicas for data backup and file level restore., ... (PRWEB) March 18, 2010 -- ...
... March 18, 2010 Elbit Imaging,Ltd. ("EI") (NASDAQ: ... Services, has informed EI that its "A2/Stable" rating,on a local scale, ... principal amount of up to NIS 100 million that ... in 2010. This credit rating,would also apply to additional debentures in ...
... , ... another 81,000 SF to its portfolio and plans $500,000 in improvements to the property. ... , ... 2010 -- Ensemble Healthcare Properties (an affiliate of locally based Ensemble DevMan of Arizona) in ...
... Wendei Spale, ... Cancer. ,She provides oncology patients with the comfort and relief that has not previously been ... suit their individual needs, at her wonderfully private studio, Peace of Mind Skin Care. , ... Studio City, CA (PRWEB) ...
Cached Medicine News:Health News:Minnesota Organizations Join Together to Save 500 Lives 2Health News:Minnesota Organizations Join Together to Save 500 Lives 3Health News:Minnesota Organizations Join Together to Save 500 Lives 4Health News:Minnesota Organizations Join Together to Save 500 Lives 5Health News:PROLOR Biotech Announces Sale of $24.4 Million of Common Stock 2Health News:PROLOR Biotech Announces Sale of $24.4 Million of Common Stock 3Health News:PROLOR Biotech Announces Sale of $24.4 Million of Common Stock 4Health News:SAN SnapShot Backup for VMWare - Does Your Backup Always Completes In Seconds, Is 1000x Faster and Costs 90% Less? 2Health News:SAN SnapShot Backup for VMWare - Does Your Backup Always Completes In Seconds, Is 1000x Faster and Costs 90% Less? 3Health News:Midroog Ltd., an Affiliate of Moody's Investors Services, Rates Potential new Debt of Elbit Imaging 2Health News:Midroog Ltd., an Affiliate of Moody's Investors Services, Rates Potential new Debt of Elbit Imaging 3Health News:Midroog Ltd., an Affiliate of Moody's Investors Services, Rates Potential new Debt of Elbit Imaging 4Health News:Ensemble Healthcare Properties Purchases North Valley Medical Plaza 2Health News:Ensemble Healthcare Properties Purchases North Valley Medical Plaza 3Health News:Peace of Mind Skin Care Announces new Services in Oncology Esthetics 2
... The assay is an immunometric ... measurement of Prolactin in human ... the sample is bound by ... different epitopes. One antibody is ...
... hormone secreted in significant amounts by the ... in synergy with estrogen, plays an important ... of mammary gland growth and lactation in ... effects on cell growth in other tissues ...
... The AxSYM BNP assay allows ... in the status of your heart ... BNP versus NT-ProBNP. The AxSYM BNP ... fast, simple, walk-away resultson a platform ...
... this Enzyme ImmunoAssay (EIA) is as follows: ... on a 96 well microtiter plate. After ... the trapped molecule is covalently linked to ... After washing and denaturing treatment, Angiotensin II ...
Medicine Products: